1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA EIF2S2 CTRPv2 pan-cancer AAC -0.14 3e-05
mRNA HDLBP CTRPv2 pan-cancer AAC -0.15 3e-05
mRNA NSD1 CTRPv2 pan-cancer AAC 0.13 3e-05
mRNA KIAA1958 CTRPv2 pan-cancer AAC 0.15 3e-05
mRNA DHX9 CTRPv2 pan-cancer AAC 0.14 3e-05
mRNA OST4 CTRPv2 pan-cancer AAC -0.14 3e-05
mRNA C3orf70 CTRPv2 pan-cancer AAC 0.15 3e-05
mRNA PGBD5 CTRPv2 pan-cancer AAC 0.14 3e-05
mRNA NBEAL1 CTRPv2 pan-cancer AAC -0.15 3e-05
mRNA SAMD14 CTRPv2 pan-cancer AAC 0.15 3e-05
Download CSV